questionsmedicales.fr
Environnement et santé publique
Santé publique
Méthodes épidémiologiques
Caractéristiques des études épidémiologiques
Études épidémiologiques
Études épidémiologiques : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Études épidémiologiques : Questions médicales les plus fréquentes",
"headline": "Études épidémiologiques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Études épidémiologiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-16",
"dateModified": "2025-05-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Études épidémiologiques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Caractéristiques des études épidémiologiques",
"url": "https://questionsmedicales.fr/mesh/D016020",
"about": {
"@type": "MedicalCondition",
"name": "Caractéristiques des études épidémiologiques",
"code": {
"@type": "MedicalCode",
"code": "D016020",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.450"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Études cas-témoins",
"alternateName": "Case-Control Studies",
"url": "https://questionsmedicales.fr/mesh/D016022",
"about": {
"@type": "MedicalCondition",
"name": "Études cas-témoins",
"code": {
"@type": "MedicalCode",
"code": "D016022",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.450.500.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Études de cohortes",
"alternateName": "Cohort Studies",
"url": "https://questionsmedicales.fr/mesh/D015331",
"about": {
"@type": "MedicalCondition",
"name": "Études de cohortes",
"code": {
"@type": "MedicalCode",
"code": "D015331",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.450.500.750"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Études de suivi",
"alternateName": "Follow-Up Studies",
"url": "https://questionsmedicales.fr/mesh/D005500",
"about": {
"@type": "MedicalCondition",
"name": "Études de suivi",
"code": {
"@type": "MedicalCode",
"code": "D005500",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.450.500.750.350"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Études longitudinales",
"alternateName": "Longitudinal Studies",
"url": "https://questionsmedicales.fr/mesh/D008137",
"about": {
"@type": "MedicalCondition",
"name": "Études longitudinales",
"code": {
"@type": "MedicalCode",
"code": "D008137",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.450.500.750.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Étude longitudinale sur la santé des adolescents aux États-Unis",
"alternateName": "National Longitudinal Study of Adolescent Health",
"url": "https://questionsmedicales.fr/mesh/D063588",
"about": {
"@type": "MedicalCondition",
"name": "Étude longitudinale sur la santé des adolescents aux États-Unis",
"code": {
"@type": "MedicalCode",
"code": "D063588",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.450.500.750.500.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Étude longitudinale sur la santé des adolescents aux États-Unis",
"alternateName": "National Longitudinal Study of Adolescent Health",
"url": "https://questionsmedicales.fr/mesh/D063588",
"about": {
"@type": "MedicalCondition",
"name": "Étude longitudinale sur la santé des adolescents aux États-Unis",
"code": {
"@type": "MedicalCode",
"code": "D063588",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.450.500.750.500.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Études prospectives",
"alternateName": "Prospective Studies",
"url": "https://questionsmedicales.fr/mesh/D011446",
"about": {
"@type": "MedicalCondition",
"name": "Études prospectives",
"code": {
"@type": "MedicalCode",
"code": "D011446",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.450.500.750.650"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Études rétrospectives",
"alternateName": "Retrospective Studies",
"url": "https://questionsmedicales.fr/mesh/D012189",
"about": {
"@type": "MedicalCondition",
"name": "Études rétrospectives",
"code": {
"@type": "MedicalCode",
"code": "D012189",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.450.500.750.825"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Études contrôlées avant-après",
"alternateName": "Controlled Before-After Studies",
"url": "https://questionsmedicales.fr/mesh/D065187",
"about": {
"@type": "MedicalCondition",
"name": "Études contrôlées avant-après",
"code": {
"@type": "MedicalCode",
"code": "D065187",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.450.500.812"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Études transversales",
"alternateName": "Cross-Sectional Studies",
"url": "https://questionsmedicales.fr/mesh/D003430",
"about": {
"@type": "MedicalCondition",
"name": "Études transversales",
"code": {
"@type": "MedicalCode",
"code": "D003430",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.450.500.875"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Analyse de série chronologique interrompue",
"alternateName": "Interrupted Time Series Analysis",
"url": "https://questionsmedicales.fr/mesh/D065186",
"about": {
"@type": "MedicalCondition",
"name": "Analyse de série chronologique interrompue",
"code": {
"@type": "MedicalCode",
"code": "D065186",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.450.500.912"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Études séroépidémiologiques",
"alternateName": "Seroepidemiologic Studies",
"url": "https://questionsmedicales.fr/mesh/D016036",
"about": {
"@type": "MedicalCondition",
"name": "Études séroépidémiologiques",
"code": {
"@type": "MedicalCode",
"code": "D016036",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.450.500.950"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Séroprévalence du VIH",
"alternateName": "HIV Seroprevalence",
"url": "https://questionsmedicales.fr/mesh/D015528",
"about": {
"@type": "MedicalCondition",
"name": "Séroprévalence du VIH",
"code": {
"@type": "MedicalCode",
"code": "D015528",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.450.500.950.375"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Études épidémiologiques",
"alternateName": "Epidemiologic Studies",
"code": {
"@type": "MedicalCode",
"code": "D016021",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Ping Liu",
"url": "https://questionsmedicales.fr/author/Ping%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Guangdong Key Laboratory of Animal Conservation and Resource Utilization, Guangdong Public Laboratory of Wild Animal Conservation and Utilization, Institute of Zoology, Guangdong Academy of Sciences, Guangzhou, China."
}
},
{
"@type": "Person",
"name": "Yuji Fujikura",
"url": "https://questionsmedicales.fr/author/Yuji%20Fujikura",
"affiliation": {
"@type": "Organization",
"name": "Department of Medical Risk Management and Infection Control, National Defense Medical College Hospital, Tokorozawa, Saitama, Japan."
}
},
{
"@type": "Person",
"name": "Takaaki Hamamoto",
"url": "https://questionsmedicales.fr/author/Takaaki%20Hamamoto",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Laboratory, National Defence Medical College Hospital, Tokorozawa, Saitama, Japan."
}
},
{
"@type": "Person",
"name": "Atsushi Yuki",
"url": "https://questionsmedicales.fr/author/Atsushi%20Yuki",
"affiliation": {
"@type": "Organization",
"name": "Department of Medical Risk Management and Infection Control, National Defense Medical College Hospital, Tokorozawa, Saitama, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Diagnostic accuracy of an iPad application for detection of visual field defects.",
"datePublished": "2022-09-05",
"url": "https://questionsmedicales.fr/article/36064770",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41433-022-02223-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Influence of Protective Headgear on the Visual Field of Recreational-Level Skiers.",
"datePublished": "2022-08-25",
"url": "https://questionsmedicales.fr/article/36078342",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph191710626"
}
},
{
"@type": "ScholarlyArticle",
"name": "Binocular visual field in adults with horizontal strabismus and driving requirements.",
"datePublished": "2022-12-02",
"url": "https://questionsmedicales.fr/article/36460857",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41433-022-02319-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "The resolution of face perception varies systematically across the visual field.",
"datePublished": "2024-05-13",
"url": "https://questionsmedicales.fr/article/38739635",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0303400"
}
},
{
"@type": "ScholarlyArticle",
"name": "Eye and head movements in visual search in the extended field of view.",
"datePublished": "2024-04-17",
"url": "https://questionsmedicales.fr/article/38632334",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-59657-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Environnement et santé publique",
"item": "https://questionsmedicales.fr/mesh/D004778"
},
{
"@type": "ListItem",
"position": 3,
"name": "Santé publique",
"item": "https://questionsmedicales.fr/mesh/D011634"
},
{
"@type": "ListItem",
"position": 4,
"name": "Méthodes épidémiologiques",
"item": "https://questionsmedicales.fr/mesh/D004812"
},
{
"@type": "ListItem",
"position": 5,
"name": "Caractéristiques des études épidémiologiques",
"item": "https://questionsmedicales.fr/mesh/D016020"
},
{
"@type": "ListItem",
"position": 6,
"name": "Études épidémiologiques",
"item": "https://questionsmedicales.fr/mesh/D016021"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Études épidémiologiques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Études épidémiologiques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Études épidémiologiques",
"description": "Comment les études épidémiologiques aident-elles au diagnostic ?\nQuels outils sont utilisés dans ces études ?\nQuelle est l'importance des cohortes dans le diagnostic ?\nLes études épidémiologiques peuvent-elles prédire des épidémies ?\nComment les biais affectent-ils le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D016021?mesh_terms=Visual+Fields&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Études épidémiologiques",
"description": "Quels symptômes sont souvent étudiés en épidémiologie ?\nComment les symptômes sont-ils collectés ?\nLes symptômes peuvent-ils varier selon les populations ?\nQuel rôle jouent les symptômes dans l'épidémiologie ?\nLes symptômes sont-ils toujours fiables ?",
"url": "https://questionsmedicales.fr/mesh/D016021?mesh_terms=Visual+Fields&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Études épidémiologiques",
"description": "Quel est le rôle des études épidémiologiques en prévention ?\nComment les campagnes de vaccination sont-elles évaluées ?\nQuels comportements de santé sont souvent étudiés ?\nLes études épidémiologiques aident-elles à la sensibilisation ?\nComment les politiques de santé publique sont-elles influencées ?",
"url": "https://questionsmedicales.fr/mesh/D016021?mesh_terms=Visual+Fields&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Études épidémiologiques",
"description": "Comment les études épidémiologiques influencent-elles les traitements ?\nQuels types de traitements sont souvent évalués ?\nLes traitements varient-ils selon les régions ?\nComment les effets secondaires sont-ils pris en compte ?\nLes traitements sont-ils adaptés aux populations spécifiques ?",
"url": "https://questionsmedicales.fr/mesh/D016021?mesh_terms=Visual+Fields&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Études épidémiologiques",
"description": "Quelles complications sont souvent étudiées ?\nComment les complications sont-elles mesurées ?\nLes complications peuvent-elles être évitées ?\nQuel impact ont les complications sur la santé publique ?\nComment les études évaluent-elles les complications ?",
"url": "https://questionsmedicales.fr/mesh/D016021?mesh_terms=Visual+Fields&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Études épidémiologiques",
"description": "Quels sont les principaux facteurs de risque identifiés ?\nComment les facteurs de risque sont-ils évalués ?\nLes facteurs de risque peuvent-ils changer au fil du temps ?\nQuel est l'impact des facteurs de risque sur la santé ?\nComment réduire les facteurs de risque ?",
"url": "https://questionsmedicales.fr/mesh/D016021?mesh_terms=Visual+Fields&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment les études épidémiologiques aident-elles au diagnostic ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles identifient les facteurs de risque et les populations à risque, facilitant le diagnostic précoce."
}
},
{
"@type": "Question",
"name": "Quels outils sont utilisés dans ces études ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des enquêtes, des analyses statistiques et des modèles épidémiologiques sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance des cohortes dans le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les cohortes permettent d'observer l'évolution des maladies et d'identifier des marqueurs diagnostiques."
}
},
{
"@type": "Question",
"name": "Les études épidémiologiques peuvent-elles prédire des épidémies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles analysent les tendances et les facteurs de risque pour anticiper les épidémies."
}
},
{
"@type": "Question",
"name": "Comment les biais affectent-ils le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les biais de sélection ou d'information peuvent fausser les résultats et influencer le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont souvent étudiés en épidémiologie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes varient selon les maladies, mais incluent souvent la douleur, la fatigue et la fièvre."
}
},
{
"@type": "Question",
"name": "Comment les symptômes sont-ils collectés ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont souvent collectés via des questionnaires, des entretiens ou des dossiers médicaux."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils varier selon les populations ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent différer en fonction de l'âge, du sexe et des facteurs culturels."
}
},
{
"@type": "Question",
"name": "Quel rôle jouent les symptômes dans l'épidémiologie ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils aident à identifier les maladies, à évaluer leur gravité et à orienter les traitements."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours fiables ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils peuvent être subjectifs et influencés par des facteurs psychologiques ou sociaux."
}
},
{
"@type": "Question",
"name": "Quel est le rôle des études épidémiologiques en prévention ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles identifient les facteurs de risque et les stratégies efficaces pour prévenir les maladies."
}
},
{
"@type": "Question",
"name": "Comment les campagnes de vaccination sont-elles évaluées ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont évaluées par des études épidémiologiques mesurant l'impact sur l'incidence des maladies."
}
},
{
"@type": "Question",
"name": "Quels comportements de santé sont souvent étudiés ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les comportements comme l'alimentation, l'exercice physique et le tabagisme sont fréquemment analysés."
}
},
{
"@type": "Question",
"name": "Les études épidémiologiques aident-elles à la sensibilisation ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles fournissent des données pour sensibiliser le public aux risques et aux mesures préventives."
}
},
{
"@type": "Question",
"name": "Comment les politiques de santé publique sont-elles influencées ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont basées sur des preuves issues d'études épidémiologiques pour orienter les interventions."
}
},
{
"@type": "Question",
"name": "Comment les études épidémiologiques influencent-elles les traitements ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles identifient l'efficacité des traitements en analysant les résultats dans différentes populations."
}
},
{
"@type": "Question",
"name": "Quels types de traitements sont souvent évalués ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements médicamenteux, les interventions chirurgicales et les thérapies comportementales."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon les régions ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent varier en fonction des ressources disponibles et des pratiques locales."
}
},
{
"@type": "Question",
"name": "Comment les effets secondaires sont-ils pris en compte ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les études évaluent les effets secondaires en surveillant les événements indésirables chez les patients."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils adaptés aux populations spécifiques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements doivent être adaptés en fonction des caractéristiques démographiques et génétiques."
}
},
{
"@type": "Question",
"name": "Quelles complications sont souvent étudiées ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications varient selon les maladies, incluant des infections, des maladies chroniques, etc."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles mesurées ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont mesurées par des indicateurs de santé, des taux d'hospitalisation et des décès."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être évitées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être évitées par des interventions précoces et des soins appropriés."
}
},
{
"@type": "Question",
"name": "Quel impact ont les complications sur la santé publique ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles augmentent la morbidité, les coûts de santé et affectent la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Comment les études évaluent-elles les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles analysent les données cliniques et les résultats des traitements pour identifier les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque identifiés ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le tabagisme, l'obésité, l'inactivité physique et l'hérédité."
}
},
{
"@type": "Question",
"name": "Comment les facteurs de risque sont-ils évalués ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont évalués par des études de cohorte, des études cas-témoins et des enquêtes épidémiologiques."
}
},
{
"@type": "Question",
"name": "Les facteurs de risque peuvent-ils changer au fil du temps ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les facteurs de risque peuvent évoluer en fonction des changements environnementaux et comportementaux."
}
},
{
"@type": "Question",
"name": "Quel est l'impact des facteurs de risque sur la santé ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils augmentent la probabilité de développer des maladies et affectent la santé globale des populations."
}
},
{
"@type": "Question",
"name": "Comment réduire les facteurs de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des interventions ciblées, des campagnes de sensibilisation et des changements de mode de vie peuvent aider."
}
}
]
}
]
}
Tablet-based perimetry could be used to test for glaucomatous visual field defects in settings without easy access to perimeters, although few studies have assessed diagnostic accuracy of tablet-based...
This was a prospective, cross-sectional study of patients undergoing their first Humphrey Field Analyser (HFA) visual field test at a glaucoma clinic in India. Participants underwent 24-2 SITA Standar...
203 eyes from 115 participants were included, with 82 eyes classified as moderate or worse glaucoma. iPad perimetry had an area under the receiver operating characteristic (AUROC) curve of 0.64 (95% C...
iPad perimetry using the visualFields Easy application had inadequate diagnostic accuracy to be used as a screening tool for glaucoma in this South Indian population....
The benefit of protective headgear for recreational skiers is an ongoing debate in the snow sports industry, and there are a lot of opposing opinions. Due to the dynamic conditions in which winter spo...
To determine the horizontal extent of the binocular visual field (BVF) in subjects with horizontal strabismus and whether the BVF falls below the driving standard....
Adults with congenital esotropia and infantile exotropia ≤45 Prism Dioptres (PD), and subjects with orthotropia were recruited. The manifest angle of deviation was measured using a simultaneous prism ...
Forty-nine subjects were included: 10 with orthotropia, 20 with exotropia and 19 with esotropia. The horizontal extent of BVF (degrees) was significantly smaller in esotropes (122.8 ± 18.8) than in or...
The horizontal extent of BVF is significantly smaller and more variable in adults with congenital esotropia and may fall below the driving standard....
Largest study on visual fields in subjects with horizontal strabismus including an orthotropic control group who do not have diplopia and who would otherwise meet the driving standard. Visual field qu...
The findings of this study would suggest that people with an esotropia should be offered the opportunity to have a binocular visual field test before applying for a driving license. The DVLA may want ...
Visual abilities tend to vary predictably across the visual field-for simple low-level stimuli, visibility is better along the horizontal vs. vertical meridian and in the lower vs. upper visual field....
In natural environments, head movements are required to search for objects outside the field of view (FoV). Here we investigate the power of a salient target in an extended visual search array to faci...
Optic disc drusen (ODD) are calcified deposits in the prelaminar portion of the optic nerve head. Although often asymptomatic, these deposits can cause progressive visual field defects and vision loss...
This was a retrospective cohort study including 65 eyes of 43 patients with ODD from the Duke Ophthalmic Registry. All eyes had at least 12 months of follow-up and at least 3 reliable standard automat...
Subjects were followed for an average of 7.6 ± 5.3 years. The mean rate of SAP MD change was -0.23 ± 0.26 dB/year, ranging from -1.19 to 0.13 dB/year. Fifty-seven eyes (87.7%) had slow progression (sl...
Most eyes with ODD had slow rates of visual field loss over time. Age and baseline severity were significantly associated with faster rates of visual field loss....
To evaluate the association between baseline severity of visual field (VF) damage and the initial rates of VF progression with quality of life (QOL) outcomes over an extended follow-up in glaucoma....
Retrospective cohort study....
Both eyes of 167 glaucoma or suspected glaucoma patients were followed for 10.0±0.3 years. The National Eye Institute Visual Function Questionnaire (NEI-VFQ)-25 was performed at the end of the follow-...
All models demonstrated association of worse baseline severity of VF damage with worse subsequent NEI-VFQ-25 scores. Faster rates of decline in VF mean deviation of the better eye and the mean sensiti...
Baseline severity and initial rates of change of VF damage are associated with QOL outcomes over an extended follow-up. Assessment of longitudinal VF changes, especially in better eye, provides progno...
To investigate the intereye correlations between and differences in the rates of visual field (VF) progression in eyes with bilateral open-angle glaucoma....
Retrospective, longitudinal, observational study....
Patients with bilateral open-angle glaucoma with 8 or more reliable 30 - 2 standard automated perimetry tests over a period of more than 2 years were enrolled. The rate of change of the MD (MD slope) ...
One hundred eighty-eight eyes from 94 patients (56 women) were enrolled. A significant intereye correlation of the rates of visual field progression (P = .002) was found. The mean ± standard deviation...
A significant intereye correlation in the rate of VF progression was found in eyes with bilateral open-angle glaucoma. We showed the distributions and associated factors of intereye differences in VF ...
To investigate the influence of peripapillary retinoschisis (PRS) on visual field (VF) test results in patients with primary open angle glaucoma (POAG)....
Thirty eyes of 30 patients with POAG who had PRS at least once were included. All eyes were followed-up for a minimum 5 years at 4-6-month intervals. The occurrence of PRS was determined by circumpapi...
Global MD (p=0.345) and regional VF deviations (p=0.255) did not differ significantly between immediately after and just prior to PRS formation. Global MD (p=0.846) and regional VF deviations (p=0.758...
PRS has no short-term effect on the VF sensitivity. Therefore, VF test can still be useful for evaluating glaucomatous damage even in the presence of PRS compared with OCT....
Visual input is not equally processed over space. In recent years, a right visual field advantage during free walking and standing in orientation discrimination and contrast detection task was reporte...